Correvio Pharma Corp.

CIK 1036141 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Correvio Pharma Corp..

Recent SEC filings

FiledFormAccession number
Jun 9, 202015-12G0001341004-20-000241
May 27, 2020EFFECT9999999995-20-001258
May 27, 2020POS AM0001341004-20-000226
May 27, 20206-K0001341004-20-000228
May 27, 2020S-8 POS0001341004-20-000224
May 27, 2020EFFECT9999999995-20-001264
May 27, 2020F-10POS0001341004-20-000223
May 27, 2020S-8 POS0001341004-20-000225
May 27, 202025-NSE0001354457-20-000204
May 27, 2020POS AM0001341004-20-000227
May 26, 2020SC 13G/A0001214659-20-005020
May 21, 20206-K0001279569-20-000824
May 18, 20206-K0001279569-20-000800
May 6, 20206-K0001279569-20-000680
May 4, 20206-K0001279569-20-000659
May 1, 20206-K0001279569-20-000649
Apr 30, 202020-F0001193125-20-127179
Apr 17, 20206-K0001279569-20-000564
Apr 16, 2020SC 13G0001214659-20-003430
Apr 9, 20206-K0001279569-20-000496
Mar 30, 20206-K0001279569-20-000425
Mar 30, 20206-K0001279569-20-000431
Mar 23, 20206-K0001279569-20-000369
Mar 18, 20206-K0001176256-20-000081
Mar 16, 20206-K0001279569-20-000314